Ranbaxy under fire: Will India's pharma industry be hit?

PUBLISHED ON: June 4, 2013 | Duration: 47 min, 25 sec

   
loading..
There is more trouble for Ranbaxy, this time from the European Union. The new headache for India's largest pharmaceutical company comes as it battles a huge credibility crisis after being fined $500 million by the United States for selling sub-standard drugs and faking quality tests. It is a huge blow to Ranbaxy, but more importantly, has raised serious concerns about the quality of the company's other drugs and whether we are safe.
ALSO WATCH
Buy Sun Pharma For Long Term, Says TS Harihar

................................ Advertisement ................................

................................ Advertisement ................................